Abstract
The second SARS virus, SARS-CoV-2, emerged in December 2019, and within a month was globally distributed. It was first introduced into Scotland in February 2020 associated with returning travellers and visitors. By March it was circulating in communities across the UK, and to control COVID-19 cases, and prevent overwhelming of the National Health Service (NHS), a ‘lockdown’ was introduced on 23rd March 2020 with a restriction of people’s movements. To augment the public health efforts a large-scale genome epidemiology effort (as part of the COVID-19 Genomics UK (COG-UK) consortium) resulted in the sequencing of over 5000 SARS-CoV-2 genomes by 18th August 2020 from Scottish cases, about a quarter of the estimated number of cases at that time. Here we quantify the geographical origins of the first wave introductions into Scotland from abroad and other UK regions, the spread of these SARS-CoV-2 lineages to different regions within Scotland (defined at the level of NHS Health Board) and the effect of lockdown on virus ‘success’. We estimate that approximately 300 introductions seeded lineages in Scotland, with around 25% of these lineages composed of more than five viruses, but by June circulating lineages were reduced to low levels, in line with low numbers of recorded positive cases. Lockdown was, thus, associated with a dramatic reduction in infection numbers and the extinguishing of most virus lineages. Unfortunately since the summer cases have been rising in Scotland in a second wave, with >1000 people testing positive on a daily basis, and hospitalisation of COVID-19 cases on the rise again. Examining the available Scottish genome data from the second wave, and comparing it to the first wave, we find that while some UK lineages have persisted through the summer, the majority of lineages responsible for the second wave are new introductions from outside of Scotland and many from outside of the UK. This indicates that, while lockdown in Scotland is directly linked with the first wave case numbers being brought under control, travel-associated imports (mostly from Europe or other parts of the UK) following the easing of lockdown are responsible for seeding the current epidemic population. This demonstrates that the impact of stringent public health measures can be compromised if following this, movements from regions of high to low prevalence are not minimised.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this work was received from: MRC (MC UU 1201412), Wellcome Trust Collaborator Award (206298/Z/17/Z - ARTIC Network), TCW Wellcome Trust Award 204802/Z/16/Z, Chief Scientist Office Project (COV/EDI/20/11), MRC EAVE II (MR/R008345/1), UKRI Industrial Strategy Challenge Fund BREATHE (MC_PC_19004), Scottish Government DG Health and Social Care, and Tommy's Charity (1060508, SC03928). COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute. CLIMB is funded by the Medical Research Council (MRC) through grant MR/L015080/1. SL additionally received support from Scottish Government Rural and Environment Science and Analytical Services Division as part of Centre of Expertise on Animal Disease Outbreaks (EPIC), and the BBSRC Institute Strategic Programme grant to Roslin Institute (BB/J004235/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NHS Greater Glasgow & Clyde and Lothian biorepositories gave approval for this study under 16/WS/0207NHS and 10/S1402/33 respectively. Approval from NHS Greater Glasgow & Clyde Biorepository, NHSGGC Biorepository, Level 3, Laboratory Medicine Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow G51 4TY was given for this study (16/WS/0207NHS). Approval from the East of Scotland Research Ethics Service, Tayside Committee on Medical Ethics B, Research Ethics Office, TAHSC, Residency Block C Ninewells Hospital & Medical School, Dundee, DD1 9SY was given for the South East Scotland SAHSC Human Annotated BioResource and its use in relation to NHS Lothian and other NHS research (10/S1402/33).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵12 https://www.cogconsortium.uk. Full list of consortium names and affiliations are in the appendix in the authorship.
Data Availability
We thank the Scottish NHS virology laboratories who provided samples for sequencing, the authors who have shared genome data on GISAID, https://www.gisaid.org. Our genome sequence acknowledgments can be found in the Supplementary. Online results of the analyses are displayed in http://sars2.cvr.gla.ac.uk/RiseFallScotCOVID/ (data to 2020-08-18) and http://phylodynamics.lycett.roslin.ed.ac.uk:3838/RiseFallScotCOVID/ (data to 2020-10-21) This study focuses on public health/surveillance questions in Scotland that make use of sequence data and other metadata that was collected under the activities of the COG-UK consortium (https://www.cogconsortium.uk/). COG-UK data is released and is publicly available via the ENA, GISAID and the COG-UK website.
http://sars2.cvr.gla.ac.uk/RiseFallScotCOVID/
http://phylodynamics.lycett.roslin.ed.ac.uk:3838/RiseFallScotCOVID/
